Anti-FANCA/FAA antibody [EPR16519]
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(4 Publications)
Rabbit Recombinant Monoclonal FANCA/FAA antibody. Suitable for IP, WB and reacts with Human samples. Cited in 4 publications.
View Alternative Names
FAA, FACA, FANCH, FANCA, Fanconi anemia group A protein, Protein FACA
- IP
Supplier Data
Immunoprecipitation - Anti-FANCA/FAA antibody [EPR16519] (AB201457)
FANCA/FAA was immunoprecipitated from 1mg of HeLa (Human epithelial cells from cervix adenocarcinoma) whole cell lysate with ab201457 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab201457 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/1500 dilution.
Lane 1 : HeLa whole cell lysate 10 μg (Input). Lane 2 : ab201457 IP in HeLa whole cell lysate. Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab201457 in HeLa whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 30 seconds.
All lanes:
Immunoprecipitation - Anti-FANCA/FAA antibody [EPR16519] (ab201457)
Predicted band size: 163 kDa
false
- WB
Supplier Data
Western blot - Anti-FANCA/FAA antibody [EPR16519] (AB201457)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-FANCA/FAA antibody [EPR16519] (ab201457) at 1/1000 dilution
All lanes:
Human colon lysate at 10 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1000 dilution
Predicted band size: 163 kDa
Observed band size: 163 kDa
false
Exposure time: 3min
- WB
Lab
Western blot - Anti-FANCA/FAA antibody [EPR16519] (AB201457)
Lanes 1, 5 and 9 : Wild-type HAP1 cell lysate (20 μg)
Lanes 2, 6 and 10 : FANCA/FAA beta knockout HAP1 cell lysate (20 μg)
Lanes 3, 7 and 11 : HeLa cell lysate (20 μg)
Lanes 4, 8 and 12 : HEK293 cell lysate (20 μg)
Lanes 1, 2, 3 and 4 : Green signal from target – ab201457 observed at 163 kDa
Lanes 5, 6, 7 and 8 : Red signal from loading control – ab8245 observed at 37 kDa
Lanes 9, 10, 11 and 12 : Merged (red and green) signal
ab201457 was shown to specifically react with FANCA/FAA beta when FANCA/FAA beta knockout samples were used. Wild-type and FANCA/FAA beta knockout samples were subjected to SDS-PAGE. ab201457 and ab8245 (loading control to GAPDH) were diluted 1/10000 and 1/2000 respectively and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed ab216776 secondary antibodies at 1/10000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-FANCA/FAA antibody [EPR16519] (ab201457)
Predicted band size: 163 kDa
false
- WB
Lab
Western blot - Anti-FANCA/FAA antibody [EPR16519] (AB201457)
Western blot : Anti-FANCA antibody [EPR16519] (ab201457) staining at 1/1000 dilution, shown in green; Mouse anti-CANX [CANX/1543] (ab238078) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab201457 was shown to bind specifically to FANCA. A band was observed at 163 kDa in wild-type A549 cell lysates with no signal observed at this size in FANCA knockout cell line. To generate this image, wild-type and FANCA knockout A549 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3% milk in TBS-0.1% Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
Lanes 1 - 4:
Western blot - Anti-FANCA/FAA antibody [EPR16519] (ab201457) at 1/1000 dilution
Lanes 1 - 4:
Western blot - Anti-FANCA/FAA antibody [EPR16519] - BSA and Azide free (<a href='/en-us/products/primary-antibodies/fanca-faa-antibody-epr16519-bsa-and-azide-free-ab251344'>ab251344</a>)
Lane 1:
Wild-type A549 cell lysate at 20 µg
Lane 2:
FANCA knockout A549 cell lysate at 20 µg
Lane 3:
Wild-type HAP1 cell lysate at 20 µg
Lane 4:
FANCA knockout HAP1 cell lysate at 20 µg
Observed band size: 163 kDa
false
- WB
Supplier Data
Western blot - Anti-FANCA/FAA antibody [EPR16519] (AB201457)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-FANCA/FAA antibody [EPR16519] (ab201457) at 1/10000 dilution
Lane 1:
HeLa (Human epithelial cells from cervix adenocarcinoma) whole cell lysate at 20 µg
Lane 2:
HEK-293 (Human epithelial cells from embryonic kidney) whole cell lysate at 20 µg
Lane 3:
Jurkat (Human T cell leukemia cells from peripheral blood) whole cell lysate at 20 µg
Lane 4:
A431 (Human epidermoid carcinoma) whole cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 163 kDa
Observed band size: 163 kDa
false
Exposure time: 1min
Related conjugates and formulations (1)
-
Anti-FANCA/FAA antibody [EPR16519] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
FANCA works as a part of the Fanconi anemia (FA) core complex involving around 13 proteins. This complex plays an important role in the FA DNA repair pathway facilitating the repair of interstrand DNA crosslinks. FANCA acts by orchestrating the recruitment and activation of downstream repair proteins which ensures the high-fidelity maintenance of the genetic material during cell division. Dysfunction in the FA complex where FANCA operates can lead to chromosomal instability and increased mutation rates.
Pathways
FANCA functions prominently in the Fanconi anemia pathway and is also involved in the homologous recombination repair pathway. In the FA pathway FANCA works closely with related proteins like FANCB and FANCC to initiate the DNA repair process. FANCA's interaction with these proteins allows it to execute its repair role effectively ensuring cellular genomic integrity. These pathways are critical for protecting cells from DNA damage during replication and shielding them from cancer development.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
The Journal of endocrinology 256: PubMed36622663
2023
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cell 81:2989-3006.e9 PubMed34197737
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cancer cell 39:209-224.e11 PubMed33450196
2021
Applications
Unspecified application
Species
Unspecified reactive species
International journal of biological sciences 13:923-934 PubMed28808424
2017
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com